Monitoring thyroid health during breast cancer chemotherapy
Part of Hormones & metabolism clinical trials.
This study checks whether chemotherapy for breast cancer affects thyroid function. It follows patients during treatment to see if thyroid problems develop.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman diagnosed with breast cancer (confirmed by biopsy).
- You are over 18 years old.
- You are generally able to care for yourself (ECOG score 0-2).
- You have not had any prior cancer treatment (like chemotherapy or radiation).
- You are willing to receive at least 4 cycles of chemotherapy with standard drugs like anthracyclines or taxanes.
- You do not have a history of thyroid disease and are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at changes in thinking and brain function in people with early to locally advanced breast cancer before and during chemotherapy. You may also be offered a brain MRI in a separate optional part of the research to learn more about brain changes.
This trial studies whether time-restricted eating (eating only within certain hours) during breast cancer chemotherapy is safe and helpful. Researchers want to see if it improves chemotherapy outcomes and side effects for people with stage I–III breast cancer.
This study tests if a man-made hormone (rhTSH) can make radioactive iodine therapy more effective for people with advanced thyroid cancer that has come back or spread. It aims to see if it helps find and treat cancer that doesn't respond well to standard radioactive iodine.
This study looks at how radiation therapy for breast cancer may affect the thyroid gland. It aims to see if changes in thyroid function happen during and after treatment, so doctors can better monitor and manage any side effects.
This study watches how chemotherapy and HER2-targeted drugs affect your heart during early-stage breast cancer treatment. Researchers use heart scans to catch any changes early and understand how to protect heart health.
This study monitors health problems that can happen over time in people with breast cancer while they receive usual treatments like hormone therapy, chemotherapy, and/or radiation. It may help researchers understand which extra symptoms or complications show up and when, to improve care and follow-up.
Hear when a new Breast Cancer Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.